BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30909875)

  • 1. A novel human in vitro papillomavirus type 16 positive tonsil cancer cell line with high sensitivity to radiation and cisplatin.
    Forslund O; Sugiyama N; Wu C; Ravi N; Jin Y; Swoboda S; Andersson F; Bzhalava D; Hultin E; Paulsson K; Dillner J; Schwartz S; Wennerberg J; Ekblad L
    BMC Cancer; 2019 Mar; 19(1):265. PubMed ID: 30909875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of a human papillomavirus type 16-positive tonsillar carcinoma xenograft in BALB/c nude mice.
    Letsolo BT; Faust H; Ekblad L; Wennerberg J; Forslund O
    Head Neck; 2016 Mar; 38(3):417-25. PubMed ID: 25352201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on human papillomavirus (HPV) 16 E2, E5 and E7 mRNA in HPV-positive tonsillar and base of tongue cancer in relation to clinical outcome and immunological parameters.
    Ramqvist T; Mints M; Tertipis N; Näsman A; Romanitan M; Dalianis T
    Oral Oncol; 2015 Dec; 51(12):1126-31. PubMed ID: 26421862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virological characteristics of cervical cancers carrying pure episomal form of HPV16 genome.
    Cheung JL; Cheung TH; Yu MY; Chan PK
    Gynecol Oncol; 2013 Nov; 131(2):374-9. PubMed ID: 24012799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer.
    Spanos WC; Nowicki P; Lee DW; Hoover A; Hostager B; Gupta A; Anderson ME; Lee JH
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1137-46. PubMed ID: 19917928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus-positive tonsillar carcinomas: a different tumor entity?
    Klussmann JP; Weissenborn SJ; Wieland U; Dries V; Eckel HE; Pfister HJ; Fuchs PG
    Med Microbiol Immunol; 2003 Aug; 192(3):129-32. PubMed ID: 12920586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose cisplatin converts the tumor microenvironment into a permissive state for HSVtk-induced antitumor immunity in HPV16-related tonsillar carcinoma.
    Goh AR; Shin SP; Jung NR; Ryu CH; Eom HS; Lee JH; Choi K; Lee SJ; Jung YS
    Cancer Lett; 2015 Jan; 356(2 Pt B):743-50. PubMed ID: 25449436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Situation of HPV16 E2 gene status during radiotherapy treatment of cervical carcinoma.
    Kahla S; Kochbati L; Maalej M; Oueslati R
    Asian Pac J Cancer Prev; 2014; 15(6):2869-73. PubMed ID: 24761916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short half-life of HPV16 E6 and E7 mRNAs sensitizes HPV16-positive tonsillar cancer cell line HN26 to DNA-damaging drugs.
    Wu C; Nilsson K; Zheng Y; Ekenstierna C; Sugiyama N; Forslund O; Kajitani N; Yu H; Wennerberg J; Ekblad L; Schwartz S
    Int J Cancer; 2019 Jan; 144(2):297-310. PubMed ID: 30303514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo.
    Jung HS; Rajasekaran N; Song SY; Kim YD; Hong S; Choi HJ; Kim YS; Choi JS; Choi YL; Shin YK
    Int J Mol Sci; 2015 May; 16(6):12243-60. PubMed ID: 26035754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas.
    Klussmann JP; Weissenborn SJ; Wieland U; Dries V; Kolligs J; Jungehuelsing M; Eckel HE; Dienes HP; Pfister HJ; Fuchs PG
    Cancer; 2001 Dec; 92(11):2875-84. PubMed ID: 11753961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of HPV16 gene expression profiles in cervical and in oropharyngeal squamous cell carcinoma.
    Cerasuolo A; Annunziata C; Tortora M; Starita N; Stellato G; Greggi S; Maglione MG; Ionna F; Losito S; Botti G; Buonaguro L; Buonaguro FM; Tornesello ML
    Oncotarget; 2017 May; 8(21):34070-34081. PubMed ID: 28423662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signature patterns of human papillomavirus type 16 in invasive anal carcinoma.
    Valmary-Degano S; Jacquin E; Prétet JL; Monnien F; Girardo B; Arbez-Gindre F; Joly M; Bosset JF; Kantelip B; Mougin C
    Hum Pathol; 2013 Jun; 44(6):992-1002. PubMed ID: 23266444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation status of HPV16 E2-binding sites classifies subtypes of HPV-associated oropharyngeal cancers.
    Reuschenbach M; Huebbers CU; Prigge ES; Bermejo JL; Kalteis MS; Preuss SF; Seuthe IM; Kolligs J; Speel EJ; Olthof N; Kremer B; Wagner S; Klussmann JP; Vinokurova S; von Knebel Doeberitz M
    Cancer; 2015 Jun; 121(12):1966-76. PubMed ID: 25731880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus does not have a causal role in colorectal carcinogenesis.
    Lorenzon L; Mazzetta F; Pilozzi E; Uggeri G; Torrisi MR; Ferri M; Ziparo V; French D
    World J Gastroenterol; 2015 Jan; 21(1):342-50. PubMed ID: 25574110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus genotype distribution in tonsil cancers.
    St Guily JL; Clavel C; Okaïs C; Prétet JL; Beby-Defaux A; Agius G; Birembaut P; Jacquard AC; Léocmach Y; Soubeyrand B; Riethmuller D; Denis F; Mougin C
    Head Neck Oncol; 2011 Feb; 3(1):6. PubMed ID: 21299882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication of cervical cancer in vivo by an AAV vector that encodes shRNA targeting human papillomavirus type 16 E6/E7.
    Sato N; Saga Y; Uchibori R; Tsukahara T; Urabe M; Kume A; Fujiwara H; Suzuki M; Ozawa K; Mizukami H
    Int J Oncol; 2018 Mar; 52(3):687-696. PubMed ID: 29344635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of the integration status for human papillomavirus 16 in esophageal carcinoma samples.
    Li S; Shen H; Li J; Hou X; Zhang K; Li J
    Turk J Gastroenterol; 2018 Mar; 29(2):157-163. PubMed ID: 29749321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of human papillomavirus (HPV) 16 DNA integration and the ensuing patterns of methylation in HPV-associated head and neck squamous cell carcinoma cell lines.
    Hatano T; Sano D; Takahashi H; Hyakusoku H; Isono Y; Shimada S; Sawakuma K; Takada K; Oikawa R; Watanabe Y; Yamamoto H; Itoh F; Myers JN; Oridate N
    Int J Cancer; 2017 Apr; 140(7):1571-1580. PubMed ID: 28006857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of human papillomavirus in head and neck cancers.
    Fakhry C; Gillison ML
    J Clin Oncol; 2006 Jun; 24(17):2606-11. PubMed ID: 16763272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.